XML 49 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Segment and Geographic Data
 12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Segment and Geographic Data SEGMENT AND GEOGRAPHIC DATA
We segregate our operations into two reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine which aligns to our internal reporting structure and how the Company manages its businesses.
The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.
Segment Results202220212020
MedSurg and Neurotechnology$10,611 $9,538 $8,345 
Orthopaedics and Spine7,838 7,570 6,006 
Net sales$18,449 $17,108 $14,351 
MedSurg and Neurotechnology$540 $518 $496 
Orthopaedics and Spine614 629 458 
Segment depreciation and amortization $1,154 $1,147 $954 
Corporate and Other124 125 122 
Total depreciation and amortization$1,278 $1,272 $1,076 
MedSurg and Neurotechnology$2,737 $2,807 $2,414 
Orthopaedics and Spine2,296 2,180 1,588 
Segment operating income$5,033 $4,987 $4,002 
Items not allocated to segments:
Corporate and Other$(649)$(605)$(503)
Acquisition and integration-related charges(150)(585)(242)
Amortization of intangible assets(627)(619)(472)
Restructuring-related and other charges(349)(386)(458)
   Goodwill impairment(216)— — 
Medical device regulations(140)(107)(81)
Recall-related matters15 (103)(17)
Regulatory and legal matters(76)2 (6)
Consolidated operating income$2,841 $2,584 $2,223 
Segment Assets and Capital Spending
Assets:202220212020
MedSurg and Neurotechnology$18,283 $15,218 $15,250 
Orthopaedics and Spine17,295 18,149 18,090 
Total segment assets$35,578 $33,367 $33,340 
Corporate and Other1,306 1,264 990 
Total assets$36,884 $34,631 $34,330 
Purchases of property, plant and equipment:
MedSurg and Neurotechnology$173 $197 $192 
Orthopaedics and Spine175 165 150 
Total segment purchases of property, plant and equipment$348 $362 $342 
Corporate and Other240 163 145 
Total purchases of property, plant and equipment$588 $525 $487 
We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring-related and other charges, goodwill impairment, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally property, plant and equipment, and noncurrent assets.
The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated.
Geographic Information
Net SalesNet Property, Plant and Equipment
20222021202020222021
United States$13,638 $12,321 $10,455 $1,791 $1,717 
Europe, Middle East, Africa2,348 2,299 1,818 995 941 
Asia Pacific1,885 1,973 1,630 76 76 
Other countries578 515 448 108 99 
Total$18,449 $17,108 $14,351 $2,970 $2,833